<http://schema.org/description>
"The threat of patent expiration on Lantus and competing diabetes drugs from Eli Lilly (LLY) and Novo Nordisk (NVO) could weigh on Sanofi&amp;#39;s (SNY) dividend."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2014/06/23/is-sanofis-dividend-safe.aspx>